Current stock page

Catalysts

CAH Stock Catalysts

Earnings · Growth Drivers · Events · AIQ Catalyst

HealthcareMedical - DistributionScore data as of Sep 4, 2026

CAH

Catalysts
Cardinal Health, Inc.
Healthcare· Medical - Distribution
AIQ Score
NeutralAIQ Edge 7/10
Low Priority
Above Peers
Score data as of Sep 4, 2026
Last price
$247.18
-$1.43 (-0.58%)
Latest market quote
Momentum79
Value57
Quality32
Risk Resilience56
Sentiment
View financial data

Stock Catalyst Board

Earnings timing, analyst expectations, news pressure, growth drivers, events, and AIQ Catalyst context.

Next earnings
Oct 29, 2026

Upcoming reporting date available for this company.

AIQ Catalyst
AIQ 55/100

Momentum 79/100 and sentiment before the next covered event.

Recent coverage
0 articles

Updated · Sentiment not scored

Earnings History And Surprises

See whether reported EPS and revenue have consistently exceeded or missed analyst expectations.

Earnings Expectations And Results

Compare what analysts expected with what the company reported across recent quarters.

Momentum 79/100AIQ Edge 7/10 Above Peers
Beat rate
100%
8 of 8 reported periods
Average surprise
+12.6%
Across covered historical reports
Latest result
+20.2%
Aug 11, 2026
EPS estimate versus actual
Actual bars are colored by beat, inline result, or miss.
Earnings history
Report dateFiscal periodEPS estimateEPS actualEPS surpriseRevenue estimateRevenue actual
Aug 11, 2026$2.42$2.91+20.2%$65.15B$63.67B
Apr 30, 2026$2.79$3.17+13.6%$62.1B$60.94B
Feb 5, 2026$2.34$2.63+12.4%$65.08B$65.63B
Oct 30, 2025$2.18$2.55+17.0%$59.24B$64.01B
Aug 12, 2025$2.04$2.08+2.0%$60.89B$60.16B
May 1, 2025$2.17$2.35+8.3%$55.39B$54.88B
Jan 30, 2025$1.74$1.93+10.9%$55.02B$55.26B
Nov 1, 2024$1.62$1.88+16.0%$50.9B$52.28B

Analyst Forecast And Price Targets

Wall Street consensus, rating distribution, and the current 12-month target range.

Analyst ratings
Buy
15
Buy
3
Hold
12-month analyst target
$268.42
+8.59% versus current price
Based on 9 analyst observations. Targets are estimates, not predictions.
Low target
$240.00
-2.90% vs latest price
Average target
$268.42
+8.59% vs latest price
High target
$292.00
+18.13% vs latest price

Event Read

Catalysts should explain what can change the setup, when it might happen, and which AIQ component would move first.

Current event setup

Event dateOct 29, 2026

Next known earnings or reporting date.

EPS estimate$2.92

Current analyst expectation for the upcoming report.

Revenue estimate$66.71B

Current analyst expectation for the upcoming report.

Sentiment score

News pressure around the setup.

Momentum score79

Where event reaction would show up first.

AIQ score55/100

Composite decision read before event confirmation.

Analyst context

Consensus
Buy
Analysts
9
Average target
$268.42
Target upside
8.59%
Target range
$240.00 - $292.00
90-day revisions
5

News And Sentiment

Recent company coverage, scored where source sentiment is available.

No recent articles have a scored sentiment label.
Positive
0
Neutral
0
Negative
0

No recent company-specific news is available.

Open full news and sentiment

CAH Catalysts FAQ

What are the next catalysts for CAH stock?

CAH's next stock catalysts can include earnings, guidance, analyst ratings, price-target changes, estimate revisions, product updates, regulatory events, contracts, or sector developments. Use this page to connect those events with AIQ and market context.

What upcoming events could move CAH stock?

Upcoming events that could move CAH include earnings reports, management commentary, estimate changes, major news, and market-wide sector catalysts.

How could CAH's next earnings report affect the stock?

CAH's next earnings report could affect the stock by changing revenue expectations, EPS estimates, guidance, analyst ratings, price targets, estimate revisions, and momentum.

What could drive CAH stock higher?

CAH could move higher if earnings, guidance, demand trends, analyst expectations, or AIQ momentum improve relative to what the market already expects.

What events could hurt CAH stock?

CAH could be hurt by weaker guidance, negative estimate revisions, margin pressure, adverse news, regulatory issues, or a sector-wide risk-off move.